{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,29]],"date-time":"2026-10-29T05:59:59Z","timestamp":1793253599974,"version":"4.5.0"},"reference-count":186,"publisher":"Oxford University Press (OUP)","issue":"3","license":[{"start":{"date-parts":[[2026,2,3]],"date-time":"2026-02-03T00:00:00Z","timestamp":1770076800000},"content-version":"vor","delay-in-days":2470,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"},{"start":{"date-parts":[[2019,3,7]],"date-time":"2019-03-07T00:00:00Z","timestamp":1551916800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"content-domain":{"domain":["onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2019,5,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Immune-mediated hemolytic anemia (IMHA) causes severe anemia in dogs and is associated with considerable morbidity and mortality. Treatment with various immunosuppressive and antithrombotic drugs has been described anecdotally and in previous studies, but little consensus exists among veterinarians as to the optimal regimen to employ and maintain after diagnosis of the disease. To address this inconsistency and provide evidence-based guidelines for treatment of IMHA in dogs, we identified and extracted data from studies published in the veterinary literature. We developed a novel tool for evaluation of evidence quality, using it to assess study design, diagnostic criteria, explanation of treatment regimens, and validity of statistical methods. In combination with our clinical experience and comparable guidelines for humans afflicted with autoimmune hemolytic anemia, we used the conclusions of this process to make a set of clinical recommendations regarding treatment of IMHA in dogs, which we refined subsequently by conducting several iterations of Delphi review. Additionally, we considered emerging treatments for IMHA in dogs and highlighted areas deserving of future research. Comments were solicited from several professional bodies to maximize clinical applicability before the recommendations were submitted for publication. The resulting document is intended to provide clinical guidelines for management of IMHA in dogs. These guidelines should be implemented pragmatically, with consideration of animal, owner, and veterinary factors that may vary among cases.<\/jats:p>","DOI":"10.1111\/jvim.15463","type":"journal-article","created":{"date-parts":[[2019,3,8]],"date-time":"2019-03-08T00:29:42Z","timestamp":1552004982000},"page":"1141-1172","update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":112,"title":["ACVIM consensus statement on the treatment of immune-mediated hemolytic anemia in dogs"],"prefix":"10.1093","volume":"33","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-7988-9997","authenticated-orcid":false,"given":"James W.","family":"Swann","sequence":"first","affiliation":[{"name":"Kennedy Institute of Rheumatology, University of Oxford , Oxford,","place":["United Kingdom"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4133-9487","authenticated-orcid":false,"given":"Oliver A.","family":"Garden","sequence":"additional","affiliation":[{"name":"School of Veterinary Medicine, University of Pennsylvania , Philadelphia, Pennsylvania"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4799-3372","authenticated-orcid":false,"given":"Claire L.","family":"Fellman","sequence":"additional","affiliation":[{"name":"Cummings School of Veterinary Medicine, Tufts University , North Grafton, Massachusetts"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4830-7610","authenticated-orcid":false,"given":"Barbara","family":"Glanemann","sequence":"additional","affiliation":[{"name":"Royal Veterinary College, University of London , London,","place":["United Kingdom"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7446-6987","authenticated-orcid":false,"given":"Robert","family":"Goggs","sequence":"additional","affiliation":[{"name":"College of Veterinary Medicine, Cornell University , Ithaca, New York"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1089-5640","authenticated-orcid":false,"given":"Dana N.","family":"LeVine","sequence":"additional","affiliation":[{"name":"College of Veterinary Medicine, Iowa State University , Ames, Iowa"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8465-0198","authenticated-orcid":false,"given":"Andrew J.","family":"Mackin","sequence":"additional","affiliation":[{"name":"College of Veterinary Medicine, Mississippi State University , Mississippi State, Mississippi"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nathaniel T.","family":"Whitley","sequence":"additional","affiliation":[{"name":"Davies Veterinary Specialists, Manor Farm Business Park , Huntingdon,","place":["United Kingdom"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2019,5,1]]},"reference":[{"key":"2026020922055355600_jvim15463-bib-0001","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1111\/j.1749-6632.1965.tb18956.x","article-title":"Autoimmune diseases in domestic animals","volume":"124","author":"Lewis","year":"1965","journal-title":"Ann N Y Acad Sci"},{"key":"2026020922055355600_jvim15463-bib-0002","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1186\/1746-6148-7-15","article-title":"Lack of evidence of a beneficial effect of azathioprine in dogs treated with prednisolone for idiopathic immune-mediated hemolytic anemia: a retrospective cohort study","volume":"7","author":"Piek","year":"2011","journal-title":"BMC Vet Res"},{"key":"2026020922055355600_jvim15463-bib-0003","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/jvim.12028","article-title":"Systematic review of evidence relating to the treatment of immune-mediated hemolytic anemia in dogs","volume":"27","author":"Swann","year":"2013","journal-title":"J Vet Intern Med"},{"key":"2026020922055355600_jvim15463-bib-0004","doi-asserted-by":"crossref","first-page":"232","DOI":"10.2460\/javma.2004.224.232","article-title":"Case-control study of blood type, breed, sex, and bacteremia in dogs with immune-mediated hemolytic anemia","volume":"224","author":"Miller","year":"2004","journal-title":"J Am Vet Med Assoc"},{"key":"2026020922055355600_jvim15463-bib-0005","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1111\/j.1748-5827.2011.01074.x","article-title":"Evaluation of immunosuppressive regimens for immune-mediated haemolytic anaemia: a retrospective study of 42 dogs","volume":"52","author":"Swann","year":"2011","journal-title":"J Small Anim Pract"},{"key":"2026020922055355600_jvim15463-bib-0006","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1111\/jsap.12107","article-title":"Treatment of canine idiopathic immune-mediated haemolytic anaemia with mycophenolate mofetil and glucocorticoids: 30 cases (2007 to 2011)","volume":"54","author":"Wang","year":"2013","journal-title":"J Small Anim Pract"},{"key":"2026020922055355600_jvim15463-bib-0007","doi-asserted-by":"crossref","first-page":"1869","DOI":"10.2460\/javma.2005.226.1869","article-title":"Evaluation of prognostic factors, survival rates, and treatment protocols for immune-mediated hemolytic anemia in dogs: 151 cases (1993-2002)","volume":"226","author":"Weinkle","year":"2005","journal-title":"J Am Vet Med Assoc"},{"key":"2026020922055355600_jvim15463-bib-0008","doi-asserted-by":"crossref","first-page":"220","DOI":"10.5326\/15473317-37-3-220","article-title":"Hemostatic abnormalities in dogs with primary immune-mediated hemolytic anemia","volume":"37","author":"Scott-Moncrieff","year":"2001","journal-title":"J Am Anim Hosp Assoc"},{"key":"2026020922055355600_jvim15463-bib-0009","doi-asserted-by":"crossref","first-page":"504","DOI":"10.1111\/j.1939-1676.2002.tb02378.x","article-title":"Prognostic factors for mortality and thromboembolism in canine immune-mediated hemolytic anemia: a retrospective study of 72 dogs","volume":"16","author":"Carr","year":"2002","journal-title":"J Vet Intern Med"},{"key":"2026020922055355600_jvim15463-bib-0010","doi-asserted-by":"crossref","first-page":"246","DOI":"10.2460\/javma.1989.195.02.246","article-title":"Pulmonary thromboembolism associated with immune-mediated hemolytic anemia in dogs: ten cases (1982-1987)","volume":"195","author":"Klein","year":"1989","journal-title":"J Am Vet Med Assoc"},{"key":"2026020922055355600_jvim15463-bib-0011","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1111\/j.1939-1676.2010.0656.x","article-title":"A prospective study of clopidogrel therapy in dogs with primary immune-mediated hemolytic anemia","volume":"25","author":"Mellett","year":"2011","journal-title":"J Vet Intern Med"},{"key":"2026020922055355600_jvim15463-bib-0012","doi-asserted-by":"crossref","first-page":"264","DOI":"10.7326\/0003-4819-151-4-200908180-00135","article-title":"Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement","volume":"151","author":"Moher","year":"2009","journal-title":"Ann Intern Med"},{"key":"2026020922055355600_jvim15463-bib-0013","doi-asserted-by":"crossref","first-page":"1278","DOI":"10.1097\/CCM.0000000000001670","article-title":"The fragility index in multicenter randomized controlled critical care trials","volume":"44","author":"Ridgeon","year":"2016","journal-title":"Crit Care Med"},{"key":"2026020922055355600_jvim15463-bib-0014","first-page":"160","article-title":"Evaluation of different prognostic markers in dogs with primary immune-mediated hemolytic anemia","volume":"123","author":"Griebsch","year":"2010","journal-title":"Berl Munch Tierarztl Wochenschr"},{"key":"2026020922055355600_jvim15463-bib-0015","doi-asserted-by":"crossref","first-page":"446","DOI":"10.5326\/0400446","article-title":"Effect of a single plasma transfusion on thromboembolism in 13 dogs with primary immune-mediated hemolytic anemia","volume":"40","author":"Thompson","year":"2004","journal-title":"J Am Anim Hosp Assoc"},{"key":"2026020922055355600_jvim15463-bib-0016","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1111\/j.1939-1676.2000.tb02256.x","article-title":"Treatment of immune-mediated hemolytic anemia in dogs with cyclophosphamide","volume":"14","author":"Burgess","year":"2000","journal-title":"J Vet Intern Med"},{"key":"2026020922055355600_jvim15463-bib-0017","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1136\/vr.163.11.323","article-title":"Concurrent immune-mediated haemolytic anaemia and severe thrombocytopenia in 21 dogs","volume":"163","author":"Goggs","year":"2008","journal-title":"Vet Rec"},{"key":"2026020922055355600_jvim15463-bib-0018","doi-asserted-by":"crossref","first-page":"543","DOI":"10.2460\/javma.2001.218.543","article-title":"Influence of drug treatment on survival of dogs with immune-mediated hemolytic anemia: 88 cases (1989\u20131999)","volume":"218","author":"Grundy","year":"2001","journal-title":"J Am Vet Med Assoc"},{"key":"2026020922055355600_jvim15463-bib-0019","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1111\/j.1939-1676.2003.tb02435.x","article-title":"Cyclophosphamide exerts no beneficial effect over prednisone alone in the initial treatment of acute immune-mediated hemolytic anemia in dogs: a randomized controlled clinical trial","volume":"17","author":"Mason","year":"2003","journal-title":"J Vet Intern Med"},{"key":"2026020922055355600_jvim15463-bib-0020","doi-asserted-by":"crossref","first-page":"384","DOI":"10.5326\/15473317-35-5-384","article-title":"Immune-mediated hemolytic anemia: 70 cases (1988-1996)","volume":"35","author":"Reimer","year":"1999","journal-title":"J Am Anim Hosp Assoc"},{"key":"2026020922055355600_jvim15463-bib-0021","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1024\/0036-7281.144.4.180","article-title":"Use of human intravenous immunoglobulin in dogs with primary immune mediated hemolytic anemia","volume":"144","author":"Gerber","year":"2002","journal-title":"Schweiz Arch Tierh"},{"key":"2026020922055355600_jvim15463-bib-0022","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1111\/j.1939-1676.1997.tb00475.x","article-title":"Intravenous human immunoglobulin for the treatment of immune-mediated hemolytic anemia in 13 dogs","volume":"11","author":"Kellerman","year":"1997","journal-title":"J Vet Intern Med"},{"key":"2026020922055355600_jvim15463-bib-0023","doi-asserted-by":"crossref","first-page":"171","DOI":"10.17236\/sat00151","article-title":"Efficacy of the combination of glucocorticoids, mycophenolate-mofetil and human immunoglobulin for the therapy of immune mediated haemolytic anaemia in dogs","volume":"160","author":"Oggier","year":"2018","journal-title":"Schweiz Arch Tierh"},{"key":"2026020922055355600_jvim15463-bib-0024","doi-asserted-by":"crossref","first-page":"139","DOI":"10.14405\/kjvr.2016.56.3.139","article-title":"Prognostic factors and efficacy of human intravenous immunoglobulin G in dogs with idiopathic immune-mediated hemolytic anemia: a retrospective study","volume":"56","author":"Park","year":"2016","journal-title":"Korean J Vet Res"},{"key":"2026020922055355600_jvim15463-bib-0025","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1111\/j.1476-4431.2009.00403.x","article-title":"Use of human immunoglobulin in addition to glucocorticoids for the initial treatment of dogs with immune-mediated hemolytic anemia","volume":"19","author":"Whelan","year":"2009","journal-title":"J Vet Emerg Crit Care"},{"key":"2026020922055355600_jvim15463-bib-0026","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1111\/j.1939-1676.2010.0505.x","article-title":"Treatment of immune-mediated hemolytic anemia with individually adjusted heparin dosing in dogs","volume":"24","author":"Helmond","year":"2010","journal-title":"J Vet Intern Med"},{"key":"2026020922055355600_jvim15463-bib-0027","doi-asserted-by":"crossref","first-page":"488","DOI":"10.1111\/vec.12480","article-title":"Evaluation of the safety and tolerability of rivaroxaban in dogs with presumed primary immune-mediated hemolytic anemia","volume":"26","author":"Morassi","year":"2016","journal-title":"J Vet Emerg Crit Care"},{"key":"2026020922055355600_jvim15463-bib-0028","doi-asserted-by":"crossref","first-page":"588","DOI":"10.1111\/j.1398-9995.2010.02530.x","article-title":"Grading quality of evidence and strength of recommendations in clinical practice guidelines part 3 of 3. The GRADE approach to developing recommendations","volume":"66","author":"Brozek","year":"2011","journal-title":"Allergy"},{"key":"2026020922055355600_jvim15463-bib-0029","doi-asserted-by":"crossref","first-page":"924","DOI":"10.1136\/bmj.39489.470347.AD","article-title":"GRADE: an emerging consensus on rating quality of evidence and strength of recommendations","volume":"336","author":"Guyatt","year":"2008","journal-title":"BMJ"},{"key":"2026020922055355600_jvim15463-bib-0030","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1111\/bjh.14478","article-title":"The diagnosis and management of primary autoimmune haemolytic anaemia","volume":"176","author":"Hill","year":"2017","journal-title":"Br J Haematol"},{"key":"2026020922055355600_jvim15463-bib-0031","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1111\/jvim.12292","article-title":"Comparison of 4 direct Coombs' test methods with polyclonal antiglobulins in anemic and nonanemic dogs for in-clinic or laboratory use","volume":"28","author":"Caviezel","year":"2014","journal-title":"J Vet Intern Med"},{"key":"2026020922055355600_jvim15463-bib-0032","doi-asserted-by":"crossref","DOI":"10.1111\/jvim.15441","article-title":"American College of Veterinary Internal Medicine Consensus Statement on the diagnosis of immune-mediated hemolytic anemia in dogs and cats","author":"Garden","year":"2019","journal-title":"J Vet Intern Med"},{"key":"2026020922055355600_jvim15463-bib-0033","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1111\/j.1476-4431.2010.00551.x","article-title":"The association of blood lactate concentration with outcome in dogs with idiopathic immune-mediated hemolytic anemia: 173 cases (2003-2006)","volume":"20","author":"Holahan","year":"2010","journal-title":"J Vet Emerg Crit Care"},{"key":"2026020922055355600_jvim15463-bib-0034","doi-asserted-by":"crossref","first-page":"1830","DOI":"10.1111\/jvim.12430","article-title":"Effect of duration of packed red blood cell storage on morbidity and mortality in dogs after transfusion: 3,095 cases (2001-2010)","volume":"28","author":"Hann","year":"2014","journal-title":"J Vet Intern Med"},{"key":"2026020922055355600_jvim15463-bib-0035","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1111\/vec.12530","article-title":"Retrospective evaluation of the effect of red blood cell product age on occurrence of acute transfusion-related complications in dogs: 210 cases (2010-2012)","volume":"27","author":"Maglaras","year":"2017","journal-title":"J Vet Emerg Crit Care"},{"key":"2026020922055355600_jvim15463-bib-0036","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1111\/jsap.12222","article-title":"Investigation of the effects of a polymerised bovine haemoglobin solution on tension in isolated canine saphenous artery","volume":"55","author":"Pawson","year":"2014","journal-title":"J Small Anim Pract"},{"key":"2026020922055355600_jvim15463-bib-0037","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1111\/j.1939-1676.2003.tb02423.x","article-title":"Hemoglobin solutions and tissue oxygenation","volume":"17","author":"Muir","year":"2003","journal-title":"J Vet Intern Med"},{"key":"2026020922055355600_jvim15463-bib-0038","doi-asserted-by":"crossref","first-page":"756","DOI":"10.1097\/00003246-199605000-00006","article-title":"Physiology and pharmacokinetics of a novel hemoglobin-based oxygen carrier in humans","volume":"24","author":"Hughes","year":"1996","journal-title":"Crit Care Med"},{"key":"2026020922055355600_jvim15463-bib-0039","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1111\/j.1476-4431.2009.00386.x","article-title":"A prospective, randomized comparison of Oxyglobin (HB-200) and packed red blood cell transfusion for canine babesiosis","volume":"19","author":"Zambelli","year":"2009","journal-title":"J Vet Emerg Crit Care"},{"key":"2026020922055355600_jvim15463-bib-0040","doi-asserted-by":"crossref","first-page":"783","DOI":"10.2460\/javma.1993.202.05.783","article-title":"Idiopathic immune-mediated hemolytic anemia in dogs: 42 cases (1986-1990)","volume":"202","author":"Klag","year":"1993","journal-title":"J Am Vet Med Assoc"},{"key":"2026020922055355600_jvim15463-bib-0041","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1007\/BF00368101","article-title":"Demographics of canine immune-mediated hemolytic anaemia in the southeastern United States","volume":"6","author":"Feldman","year":"1996","journal-title":"Comp Haematol Int"},{"key":"2026020922055355600_jvim15463-bib-0042","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1111\/j.1476-4431.2012.00824.x","article-title":"Prothrombotic mechanisms and anticoagulant therapy in dogs with immune-mediated hemolytic anemia","volume":"23","author":"Kidd","year":"2013","journal-title":"J Vet Emerg Crit Care"},{"key":"2026020922055355600_jvim15463-bib-0043","doi-asserted-by":"crossref","first-page":"896","DOI":"10.1160\/TH15-09-0740","article-title":"Supportive management strategies for disseminated intravascular coagulation. An international consensus","volume":"115","author":"Squizzato","year":"2016","journal-title":"Thromb Haemost"},{"key":"2026020922055355600_jvim15463-bib-0044","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1136\/vr.109.8.150","article-title":"Primary autoimmune haemolytic anaemia in the dog","volume":"109","author":"Bennett","year":"1981","journal-title":"Vet Rec"},{"key":"2026020922055355600_jvim15463-bib-0045","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1111\/j.1748-5827.1996.tb02313.x","article-title":"Serial monitoring of clinical, haematological and immunological parameters in canine autoimmune haemolytic anaemia","volume":"37","author":"Day","year":"1996","journal-title":"J Small Anim Pract"},{"key":"2026020922055355600_jvim15463-bib-0046","first-page":"121","article-title":"The autoimmune hemolytic anemia (AIHA) in dogs \u2013 a survey of the clinical picture, diagnosis, pathogenesis and therapy of 8 cases","volume":"75","author":"Schwendenwein","year":"1988","journal-title":"Wien Tierarztl Monatsschr"},{"key":"2026020922055355600_jvim15463-bib-0047","first-page":"406","article-title":"Current Veterinary Therapy XII: Small Animal Practice","author":"Behrend","year":"1995"},{"key":"2026020922055355600_jvim15463-bib-0048","first-page":"503","article-title":"Textbook of Veterinary Internal Medicine","author":"Cohn","year":"2005"},{"key":"2026020922055355600_jvim15463-bib-0049","doi-asserted-by":"crossref","first-page":"61","DOI":"10.2165\/00003088-200544010-00003","article-title":"Pharmacokinetics and pharmacodynamics of systemically administered glucocorticoids","volume":"44","author":"Czock","year":"2005","journal-title":"Clin Pharmacokinet"},{"key":"2026020922055355600_jvim15463-bib-0050","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1111\/vec.12121","article-title":"Treatment of idiopathic immune-mediated hemolytic anemia with mycophenolate mofetil in five dogs","volume":"24","author":"West","year":"2014","journal-title":"J Vet Emerg Crit Care"},{"key":"2026020922055355600_jvim15463-bib-0051","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1111\/jvim.12514","article-title":"Systematic review of prognostic factors for mortality in dogs with immune-mediated hemolytic anemia","volume":"29","author":"Swann","year":"2015","journal-title":"J Vet Intern Med"},{"key":"2026020922055355600_jvim15463-bib-0052","doi-asserted-by":"crossref","first-page":"1603","DOI":"10.1111\/jvim.13642","article-title":"Predicting outcome in dogs with primary immune-mediated hemolytic anemia: results of a multicenter case registry","volume":"29","author":"Goggs","year":"2015","journal-title":"J Vet Intern Med"},{"key":"2026020922055355600_jvim15463-bib-0053","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1080\/01652176.2011.604979","article-title":"Canine idiopathic immune-mediated haemolytic anaemia: a review with recommendations for future research","volume":"31","author":"Piek","year":"2011","journal-title":"Vet Q"},{"key":"2026020922055355600_jvim15463-bib-0054","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1111\/j.1939-1676.2008.0060.x","article-title":"Idiopathic immune-mediated hemolytic anemia: treatment outcome and prognostic factors in 149 dogs","volume":"22","author":"Piek","year":"2008","journal-title":"J Vet Intern Med"},{"key":"2026020922055355600_jvim15463-bib-0055","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1111\/vec.12286","article-title":"Use of enoxaparin in dogs with primary immune-mediated hemolytic anemia: 21 cases","volume":"25","author":"Panek","year":"2015","journal-title":"J Vet Emerg Crit Care"},{"key":"2026020922055355600_jvim15463-bib-0056","first-page":"389","article-title":"Prednisone and cyclosporine vs. prednisone alone for treatment of canine immune mediated hemolytic anemia (IMHA)","volume":"18","author":"Husbands","year":"2004","journal-title":"J Vet Intern Med"},{"key":"2026020922055355600_jvim15463-bib-0057","doi-asserted-by":"crossref","first-page":"4143","DOI":"10.1016\/S0041-1345(98)01373-6","article-title":"Leflunomide effectively treats naturally occurring immune-mediated and inflammatory diseases of dogs that are unresponsive to conventional therapy","volume":"30","author":"Gregory","year":"1998","journal-title":"Transplant Proc"},{"key":"2026020922055355600_jvim15463-bib-0058","doi-asserted-by":"crossref","first-page":"1502","DOI":"10.1111\/jvim.14810","article-title":"A retrospective study on the safety and efficacy of leflunomide in dogs","volume":"31","author":"Sato","year":"2017","journal-title":"J Vet Intern Med"},{"key":"2026020922055355600_jvim15463-bib-0059","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1111\/j.1476-4431.2011.00676.x","article-title":"A review of current indications, adverse effects, and administration recommendations for intravenous immunoglobulin","volume":"21","author":"Spurlock","year":"2011","journal-title":"J Vet Emerg Crit Care"},{"key":"2026020922055355600_jvim15463-bib-0060","doi-asserted-by":"crossref","first-page":"1623","DOI":"10.2460\/javma.1997.210.11.1623","article-title":"Intravenous administration of human immune globulin in dogs with immune-mediated hemolytic anemia","volume":"210","author":"Scott-Moncrieff","year":"1997","journal-title":"J Am Vet Med Assoc"},{"key":"2026020922055355600_jvim15463-bib-0061","first-page":"229","article-title":"Therapy of immune-mediated haemolytic anaemia in the dog using human immunoglobulin","volume":"29","author":"Link","year":"2001","journal-title":"Tierarztl Prax Ausg K Kleintiere Heimtiere"},{"key":"2026020922055355600_jvim15463-bib-0062","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1111\/j.1532-950X.2006.00121.x","article-title":"Results of clinical renal transplantation in 15 dogs using triple drug immunosuppressive therapy","volume":"35","author":"Gregory","year":"2006","journal-title":"Vet Surg"},{"key":"2026020922055355600_jvim15463-bib-0063","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1111\/j.1532-950X.2011.00924.x","article-title":"Outcome after renal transplantation in 26 dogs","volume":"41","author":"Hopper","year":"2012","journal-title":"Vet Surg"},{"key":"2026020922055355600_jvim15463-bib-0064","doi-asserted-by":"crossref","first-page":"1385","DOI":"10.1111\/jvim.12195","article-title":"Randomized, controlled trial of budesonide and prednisone for the treatment of idiopathic inflammatory bowel disease in dogs","volume":"27","author":"Dye","year":"2013","journal-title":"J Vet Intern Med"},{"key":"2026020922055355600_jvim15463-bib-0065","doi-asserted-by":"crossref","first-page":"395","DOI":"10.2460\/javma.248.4.395","article-title":"Comparison of the efficacy of prednisone and cyclosporine for treatment of dogs with primary immune-mediated polyarthritis","volume":"248","author":"Rhoades","year":"2016","journal-title":"J Am Vet Med Assoc"},{"key":"2026020922055355600_jvim15463-bib-0066","doi-asserted-by":"crossref","first-page":"411","DOI":"10.2460\/ajvr.79.4.411","article-title":"Effects of short-term anti-inflammatory glucocorticoid treatment on clinicopathologic, echocardiographic, and hemodynamic variables in systemically healthy dogs","volume":"79","author":"Masters","year":"2018","journal-title":"Am J Vet Res"},{"key":"2026020922055355600_jvim15463-bib-0067","doi-asserted-by":"crossref","first-page":"299","DOI":"10.2460\/javma.1984.185.03.299","article-title":"Transient diabetes mellitus associated with prednisone therapy in a dog","volume":"185","author":"Campbell","year":"1984","journal-title":"J Am Vet Med Assoc"},{"key":"2026020922055355600_jvim15463-bib-0068","doi-asserted-by":"crossref","first-page":"77","DOI":"10.2460\/javma.1991.199.01.77","article-title":"Diabetes mellitus induced in a dog after administration of corticosteroids and methylprednisolone pulse therapy","volume":"199","author":"Jeffers","year":"1991","journal-title":"J Am Vet Med Assoc"},{"key":"2026020922055355600_jvim15463-bib-0069","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1111\/jsap.12652","article-title":"Serial measurement of pancreatic lipase immunoreactivity concentration in dogs with immune-mediated disease treated with prednisolone","volume":"58","author":"Ohta","year":"2017","journal-title":"J Small Anim Pract"},{"key":"2026020922055355600_jvim15463-bib-0070","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1097\/BOR.0b013e3282f51031","article-title":"The epidemiology of glucocorticoid-associated adverse events","volume":"20","author":"McDonough","year":"2008","journal-title":"Curr Opin Rheumatol"},{"key":"2026020922055355600_jvim15463-bib-0071","doi-asserted-by":"crossref","first-page":"239","DOI":"10.2460\/javma.2005.227.239","article-title":"Frequency of urinary tract infection among dogs with pruritic disorders receiving long-term glucocorticoid treatment","volume":"227","author":"Torres","year":"2005","journal-title":"J Am Vet Med Assoc"},{"key":"2026020922055355600_jvim15463-bib-0072","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1111\/j.1365-3164.2012.01044.x","article-title":"Frequency of urinary tract infection in dogs with inflammatory skin disorders treated with ciclosporin alone or in combination with glucocorticoid therapy: a retrospective study","volume":"23","author":"Peterson","year":"2012","journal-title":"Vet Derm"},{"key":"2026020922055355600_jvim15463-bib-0073","doi-asserted-by":"crossref","first-page":"263768","DOI":"10.4061\/2011\/263768","article-title":"Antimicrobial use guidelines for treatment of urinary tract disease in dogs and cats: antimicrobial guidelines working group of the international society for companion animal infectious diseases","volume":"2011","author":"Weese","year":"2011","journal-title":"Vet Med Int"},{"key":"2026020922055355600_jvim15463-bib-0074","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1086\/427507","article-title":"Infectious Diseases Society of America guidelines for the diagnosis and treatment of asymptomatic bacteriuria in adults","volume":"40","author":"Nicolle","year":"2005","journal-title":"Clin Infect Dis"},{"key":"2026020922055355600_jvim15463-bib-0075","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1111\/jvim.12543","article-title":"Incidence, timing, and risk factors of azathioprine hepatotoxicosis in dogs","volume":"29","author":"Wallisch","year":"2015","journal-title":"J Vet Intern Med"},{"key":"2026020922055355600_jvim15463-bib-0076","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1111\/j.1939-1676.2004.tb02555.x","article-title":"Relationship between red blood cell thiopurine methyltransferase activity and myelotoxicity in dogs receiving azathioprine","volume":"18","author":"Rodriguez","year":"2004","journal-title":"J Vet Intern Med"},{"key":"2026020922055355600_jvim15463-bib-0077","first-page":"37","article-title":"A case of long-term inhibition of erythropoiesis by azathioprine in a dog","volume":"31","author":"Kaneko","year":"2004","journal-title":"Yamaguchi J Vet Med"},{"key":"2026020922055355600_jvim15463-bib-0078","doi-asserted-by":"crossref","first-page":"695","DOI":"10.2460\/javma.1987.191.06.695","article-title":"Acute pancreatitis in two dogs given azathioprine and prednisone","volume":"191","author":"Moriello","year":"1987","journal-title":"J Am Vet Med Assoc"},{"key":"2026020922055355600_jvim15463-bib-0079","first-page":"496","article-title":"Acute pancreatitis and bone marrow suppression in a dog given azathioprine","volume":"32","author":"Houston","year":"1991","journal-title":"Can Vet J"},{"key":"2026020922055355600_jvim15463-bib-0080","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1111\/j.1939-1676.2004.tb00163.x","article-title":"Thiopurine methyltransferase activity in red blood cells of dogs","volume":"18","author":"Kidd","year":"2004","journal-title":"J Vet Intern Med"},{"key":"2026020922055355600_jvim15463-bib-0081","doi-asserted-by":"crossref","first-page":"1855","DOI":"10.2460\/javma.2005.226.1855","article-title":"Clinical trial evaluating the efficacy and safety of cyclosporine in dogs with atopic dermatitis","volume":"226","author":"Steffan","year":"2005","journal-title":"J Am Vet Med Assoc"},{"key":"2026020922055355600_jvim15463-bib-0082","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1111\/j.1365-2885.2004.00587.x","article-title":"Cyclosporin A pharmacokinetics and efficacy in the treatment of atopic dermatitis in dogs","volume":"27","author":"Steffan","year":"2004","journal-title":"J Vet Pharmacol Ther"},{"key":"2026020922055355600_jvim15463-bib-0083","first-page":"13","article-title":"Medical Management of cyclosporine-induced gingival overgrowth using oral azithromycin in six dogs","volume":"2","author":"Diesel","year":"2015","journal-title":"Vet Sci"},{"key":"2026020922055355600_jvim15463-bib-0084","first-page":"67","article-title":"Gingival overgrowth in a dog that received long-term cyclosporine for immune-mediated hemolytic anemia","volume":"53","author":"Namikawa","year":"2012","journal-title":"Can Vet J"},{"key":"2026020922055355600_jvim15463-bib-0085","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1111\/j.1532-950X.2008.00373.x","article-title":"Gingival overgrowth in dogs associated with clinically relevant cyclosporine blood levels: observations in a canine renal transplantation model","volume":"37","author":"Nam","year":"2008","journal-title":"Vet Surg"},{"key":"2026020922055355600_jvim15463-bib-0086","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1111\/j.1748-5827.2006.00303.x","article-title":"Ciclosporin use in multi-drug therapy for meningoencephalomyelitis of unknown aetiology in dogs","volume":"48","author":"Adamo","year":"2007","journal-title":"J Small Anim Pract"},{"key":"2026020922055355600_jvim15463-bib-0087","first-page":"860","article-title":"Cyclosporin A: preliminary observations in dogs with pancreatic duodenal allografts and patients with cadaveric renal transplants","volume":"11","author":"Calne","year":"1979","journal-title":"Transplant Proc"},{"key":"2026020922055355600_jvim15463-bib-0088","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1111\/j.1939-1676.1995.tb01077.x","article-title":"The effects of cyclosporine versus standard care in dogs with naturally occurring glomerulonephritis","volume":"9","author":"Vaden","year":"1995","journal-title":"J Vet Intern Med"},{"key":"2026020922055355600_jvim15463-bib-0089","doi-asserted-by":"crossref","first-page":"1724","DOI":"10.1111\/jvim.14824","article-title":"Opportunistic invasive cutaneous fungal infections associated with administration of cyclosporine to dogs with immune-mediated disease","volume":"31","author":"McAtee","year":"2017","journal-title":"J Vet Intern Med"},{"key":"2026020922055355600_jvim15463-bib-0090","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1111\/jsap.12367","article-title":"Opportunistic fungal infections in dogs treated with ciclosporin and glucocorticoids: eight cases","volume":"57","author":"Dowling","year":"2016","journal-title":"J Small Anim Pract"},{"key":"2026020922055355600_jvim15463-bib-0091","doi-asserted-by":"crossref","first-page":"1009","DOI":"10.2460\/javma.2002.220.1009","article-title":"Cyclosporine and ketoconazole for the treatment of perianal fistulas in dogs","volume":"220","author":"Patricelli","year":"2002","journal-title":"J Am Vet Med Assoc"},{"key":"2026020922055355600_jvim15463-bib-0092","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1111\/j.1532-950X.1998.tb00099.x","article-title":"Effect of ketoconazole on cyclosporine dose in healthy dogs","volume":"27","author":"Dahlinger","year":"1998","journal-title":"Vet Surg"},{"key":"2026020922055355600_jvim15463-bib-0093","doi-asserted-by":"crossref","first-page":"1389","DOI":"10.1111\/j.1939-1676.2012.01025.x","article-title":"The effects of cyclosporine on platelet function and cyclooxygenase expression in normal dogs","volume":"26","author":"Thomason","year":"2012","journal-title":"J Vet Intern Med"},{"key":"2026020922055355600_jvim15463-bib-0094","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1111\/vde.12400","article-title":"Use of mycophenolate mofetil to treat immune-mediated skin disease in 14 dogs - a retrospective evaluation","volume":"28","author":"Ackermann","year":"2017","journal-title":"Vet Dermatol"},{"key":"2026020922055355600_jvim15463-bib-0095","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1111\/vec.12399","article-title":"Retrospective evaluation of combined mycophenolate mofetil and prednisone treatment for meningoencephalomyelitis of unknown etiology in dogs: 25 cases (2005-2011)","volume":"26","author":"Barnoon","year":"2016","journal-title":"J Vet Emerg Crit Care"},{"key":"2026020922055355600_jvim15463-bib-0096","doi-asserted-by":"crossref","first-page":"664","DOI":"10.2460\/javma.236.6.664","article-title":"Mycophenolate mofetil treatment in dogs with serologically diagnosed acquired myasthenia gravis: 27 cases (1999-2008)","volume":"236","author":"Dewey","year":"2010","journal-title":"J Am Vet Med Assoc"},{"key":"2026020922055355600_jvim15463-bib-0097","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1111\/jsap.12203","article-title":"Treatment of five haemodynamically stable dogs with immune-mediated thrombocytopenia using mycophenolate mofetil as single agent","volume":"55","author":"Yau","year":"2014","journal-title":"J Small Anim Pract"},{"key":"2026020922055355600_jvim15463-bib-0098","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1111\/vop.12545","article-title":"Clinical therapeutic efficacy of mycophenolate mofetil in the treatment of SARDS in dogs \u2013 a prospective open-label pilot study","volume":"21","author":"Young","year":"2018","journal-title":"Vet Ophthalmol"},{"key":"2026020922055355600_jvim15463-bib-0099","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1111\/jsap.12621","article-title":"Treatment of presumptive primary immune-mediated thrombocytopenia with mycophenolate mofetil versus cyclosporine in dogs","volume":"58","author":"Cummings","year":"2017","journal-title":"J Small Anim Pract"},{"key":"2026020922055355600_jvim15463-bib-0100","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1002\/vms3.22","article-title":"Treatment of canine meningoencephalomyelitis of unknown aetiology with mycophenolate mofetil and corticosteroids: 25 cases (2007-2012)","volume":"2","author":"Woolcock","year":"2016","journal-title":"Vet Med Sci"},{"key":"2026020922055355600_jvim15463-bib-0101","doi-asserted-by":"crossref","first-page":"2068","DOI":"10.1016\/j.transproceed.2004.07.057","article-title":"Safety of mycophenolate mofetil versus azathioprine in renal transplantation: a systematic review","volume":"36","author":"Wang","year":"2004","journal-title":"Transplant Proc"},{"key":"2026020922055355600_jvim15463-bib-0102","doi-asserted-by":"crossref","first-page":"1474","DOI":"10.1097\/TP.0b013e31818b62c8","article-title":"Progressive multifocal leukoencephalopathy and use of mycophenolate mofetil after kidney transplantation","volume":"86","author":"Neff","year":"2008","journal-title":"Transplantation"},{"key":"2026020922055355600_jvim15463-bib-0103","doi-asserted-by":"crossref","first-page":"312","DOI":"10.2460\/javma.236.3.312","article-title":"Efficacy of leflunomide for treatment of immune-mediated polyarthritis in dogs: 14 cases (2006-2008)","volume":"236","author":"Colopy","year":"2010","journal-title":"J Am Vet Med Assoc"},{"key":"2026020922055355600_jvim15463-bib-0104","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1292\/jvms.15-0129","article-title":"Efficacy of leflunomide for treatment of refractory inflammatory colorectal polyps in 15 Miniature Dachshunds","volume":"78","author":"Fukushima","year":"2016","journal-title":"J Vet Med Sci"},{"key":"2026020922055355600_jvim15463-bib-0105","doi-asserted-by":"crossref","first-page":"878","DOI":"10.1016\/S0041-1345(98)00084-0","article-title":"Immunosuppressive approaches to the prevention of graft vascular disease","volume":"30","author":"Gregory","year":"1998","journal-title":"Transplant Proc"},{"key":"2026020922055355600_jvim15463-bib-0106","doi-asserted-by":"crossref","first-page":"617","DOI":"10.2460\/javma.1985.187.06.617","article-title":"Splenectomy as adjunctive therapy for immune-mediated thrombocytopenia and hemolytic anemia in the dog","volume":"187","author":"Feldman","year":"1985","journal-title":"J Am Vet Med Assoc"},{"key":"2026020922055355600_jvim15463-bib-0107","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1111\/j.1476-4431.2009.00419.x","article-title":"Splenectomy as an adjunctive treatment for dogs with immune-mediated hemolytic anemia: ten cases (2003-2006)","volume":"19","author":"Horgan","year":"2009","journal-title":"J Vet Emerg Crit Care"},{"key":"2026020922055355600_jvim15463-bib-0108","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1111\/vec.12801","article-title":"American College of Veterinary Emergency and Critical Care (ACVECC) Consensus on the Rational Use of Antithrombotics in Veterinary Critical Care (CURATIVE) guidelines: small animal","volume":"29","author":"Goggs","year":"2019","journal-title":"J Vet Emerg Crit Care"},{"key":"2026020922055355600_jvim15463-bib-0109","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1053\/j.tcam.2012.07.002","article-title":"Diseases associated with thrombosis","volume":"27","author":"de Laforcade","year":"2012","journal-title":"Top Companion Anim Med"},{"key":"2026020922055355600_jvim15463-bib-0110","doi-asserted-by":"crossref","first-page":"1298","DOI":"10.1111\/j.1939-1676.2010.0593.x","article-title":"Concurrent diseases and conditions in dogs with splenic vein thrombosis","volume":"24","author":"Laurenson","year":"2010","journal-title":"J Vet Intern Med"},{"key":"2026020922055355600_jvim15463-bib-0111","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1111\/j.1939-1676.2012.00893.x","article-title":"Portal vein thrombosis in 33 dogs: 1998-2011","volume":"26","author":"Respess","year":"2012","journal-title":"J Vet Intern Med"},{"key":"2026020922055355600_jvim15463-bib-0112","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1177\/030098589303000104","article-title":"Thrombosis of the portal-vein in 11 dogs","volume":"30","author":"Vanwinkle","year":"1993","journal-title":"Vet Pathol"},{"key":"2026020922055355600_jvim15463-bib-0113","doi-asserted-by":"crossref","first-page":"1748","DOI":"10.2460\/javma.1989.195.12.1748","article-title":"Idiopathic pleural effusion and pulmonary thromboembolism in a dog with autoimmune hemolytic anemia","volume":"195","author":"Bunch","year":"1989","journal-title":"J Am Vet Med Assoc"},{"key":"2026020922055355600_jvim15463-bib-0114","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1111\/j.1939-1676.1999.tb02192.x","article-title":"Pulmonary thromboembolism in 29 dogs: 1985-1995","volume":"13","author":"Johnson","year":"1999","journal-title":"J Vet Intern Med"},{"key":"2026020922055355600_jvim15463-bib-0115","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1016\/j.vetimm.2011.08.010","article-title":"High intravascular tissue factor expression in dogs with idiopathic immune-mediated haemolytic anaemia","volume":"144","author":"Piek","year":"2011","journal-title":"Vet Immunol Immunopathol"},{"key":"2026020922055355600_jvim15463-bib-0116","doi-asserted-by":"crossref","first-page":"908","DOI":"10.1111\/jvim.12583","article-title":"Procoagulant microparticles in dogs with immune-mediated hemolytic anemia","volume":"29","author":"Kidd","year":"2015","journal-title":"J Vet Intern Med"},{"key":"2026020922055355600_jvim15463-bib-0117","doi-asserted-by":"crossref","first-page":"682","DOI":"10.1111\/j.1939-1676.2006.tb02915.x","article-title":"Detection of activated platelets in dogs with primary immune-mediated hemolytic anemia","volume":"20","author":"Weiss","year":"2006","journal-title":"J Vet Intern Med"},{"key":"2026020922055355600_jvim15463-bib-0118","doi-asserted-by":"crossref","first-page":"463","DOI":"10.2460\/javma.238.4.463","article-title":"Identification of hypercoagulability in dogs with primary immune-mediated hemolytic anemia by means of thromboelastography","volume":"238","author":"Fenty","year":"2011","journal-title":"J Am Vet Med Assoc"},{"key":"2026020922055355600_jvim15463-bib-0119","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1016\/j.tvjl.2011.03.015","article-title":"Serial assessment of the coagulation status of dogs with immune-mediated haemolytic anaemia using thromboelastography","volume":"191","author":"Goggs","year":"2012","journal-title":"Vet J"},{"key":"2026020922055355600_jvim15463-bib-0120","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1111\/jsap.12037","article-title":"Characterisation of changes in the haemostasis system in dogs with thrombosis","volume":"54","author":"Bauer","year":"2013","journal-title":"J Small Anim Pract"},{"key":"2026020922055355600_jvim15463-bib-0121","doi-asserted-by":"crossref","first-page":"1308","DOI":"10.2460\/javma.2001.218.1308","article-title":"Correlation between leukocytosis and necropsy findings in dogs with immune-mediated hemolytic anemia: 34 cases (1994-1999)","volume":"218","author":"McManus","year":"2001","journal-title":"J Am Vet Med Assoc"},{"key":"2026020922055355600_jvim15463-bib-0122","doi-asserted-by":"crossref","first-page":"1325","DOI":"10.2460\/ajvr.72.10.1325","article-title":"Independent and combined effects of prednisone and acetylsalicylic acid on thromboelastography variables in healthy dogs","volume":"72","author":"Flint","year":"2011","journal-title":"Am J Vet Res"},{"key":"2026020922055355600_jvim15463-bib-0123","first-page":"681","article-title":"Thromboelastography in dogs with immune-mediated hemolytic anemia treated with prednisone, azathioprine and low-dose aspirin","volume":"24","author":"Flint","year":"2010","journal-title":"J Vet Intern Med"},{"key":"2026020922055355600_jvim15463-bib-0124","doi-asserted-by":"crossref","first-page":"1164","DOI":"10.1111\/j.1939-1676.2009.0402.x","article-title":"Prothrombotic and inflammatory effects of intravenous administration of human immunoglobulin G in dogs","volume":"23","author":"Tsuchiya","year":"2009","journal-title":"J Vet Intern Med"},{"key":"2026020922055355600_jvim15463-bib-0125","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1111\/j.1476-4431.2010.00540.x","article-title":"Immune-mediated hemolytic anemia and severe thrombocytopenia in dogs: 12 cases (2001-2008)","volume":"20","author":"Orcutt","year":"2010","journal-title":"J Vet Emerg Crit Care"},{"key":"2026020922055355600_jvim15463-bib-0126","doi-asserted-by":"crossref","first-page":"798","DOI":"10.2460\/javma.1999.215.06.798","article-title":"Diagnosis of disseminated intravascular coagulation in dogs admitted to an intensive care unit","volume":"215","author":"Bateman","year":"1999","journal-title":"J Am Vet Med Assoc"},{"key":"2026020922055355600_jvim15463-bib-0127","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1111\/j.1939-1676.2008.0058.x","article-title":"Thromboelastographic evaluation of hemostatic function in dogs with disseminated intravascular coagulation","volume":"22","author":"Wiinberg","year":"2008","journal-title":"J Vet Intern Med"},{"key":"2026020922055355600_jvim15463-bib-0128","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1053\/j.seminhematol.2014.02.002","article-title":"Direct oral anticoagulants and bleeding risk (in comparison to vitamin K antagonists and heparins), and the treatment of bleeding","volume":"51","author":"Palareti","year":"2014","journal-title":"Semin Hematol"},{"key":"2026020922055355600_jvim15463-bib-0129","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1016\/j.tvjl.2013.05.047","article-title":"Characterization of thrombelastography over time in dogs with hyperadrenocorticism","volume":"197","author":"Kol","year":"2013","journal-title":"Vet J"},{"key":"2026020922055355600_jvim15463-bib-0130","doi-asserted-by":"crossref","first-page":"388","DOI":"10.2460\/javma.1981.178.04.388","article-title":"Pulmonary-artery thrombosis in 3 dogs with hyperadrenocorticism","volume":"178","author":"Burns","year":"1981","journal-title":"J Am Vet Med Assoc"},{"key":"2026020922055355600_jvim15463-bib-0131","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1111\/j.1538-7836.2007.02515.x","article-title":"Vascular bed-specific thrombosis","volume":"5","author":"Aird","year":"2007","journal-title":"J Thromb Haemost"},{"key":"2026020922055355600_jvim15463-bib-0132","doi-asserted-by":"crossref","first-page":"2331","DOI":"10.1172\/JCI60229","article-title":"New insights into the mechanisms of venous thrombosis","volume":"122","author":"Mackman","year":"2012","journal-title":"J Clin Invest"},{"key":"2026020922055355600_jvim15463-bib-0133","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1111\/j.1748-5827.2010.00935.x","article-title":"Evaluation of platelet activation in canine immune-mediated haemolytic anaemia","volume":"51","author":"Ridyard","year":"2010","journal-title":"J Small Anim Pract"},{"key":"2026020922055355600_jvim15463-bib-0134","doi-asserted-by":"crossref","first-page":"1384","DOI":"10.2460\/javma.252.11.1384","article-title":"Case-control study of plasma mean platelet component concentration and survival analysis for dogs with immune-mediated hemolytic anemia","volume":"252","author":"Zoia","year":"2018","journal-title":"J Am Vet Med Assoc"},{"key":"2026020922055355600_jvim15463-bib-0135","doi-asserted-by":"crossref","first-page":"958","DOI":"10.1055\/s-0037-1615947","article-title":"A cell-based model of hemostasis","volume":"85","author":"Hoffman","year":"2001","journal-title":"Thromb Haemost"},{"key":"2026020922055355600_jvim15463-bib-0136","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1111\/j.1476-4431.2009.00389.x","article-title":"The cell-based model of coagulation","volume":"19","author":"Smith","year":"2009","journal-title":"J Vet Emerg Crit Care"},{"key":"2026020922055355600_jvim15463-bib-0137","doi-asserted-by":"crossref","first-page":"488","DOI":"10.1111\/j.1365-2141.2007.06973.x","article-title":"Common risk factors for both arterial and venous thrombosis","volume":"140","author":"Lowe","year":"2008","journal-title":"Br J Haematol"},{"key":"2026020922055355600_jvim15463-bib-0138","doi-asserted-by":"crossref","first-page":"1886","DOI":"10.1111\/j.1538-7836.2006.02138.x","article-title":"Venous thromboembolism and atherosclerosis: common denominators or different diseases?","volume":"4","author":"Agnelli","year":"2006","journal-title":"J Thromb Haemost"},{"key":"2026020922055355600_jvim15463-bib-0139","doi-asserted-by":"crossref","first-page":"1882","DOI":"10.1111\/j.1538-7836.2006.02130.x","article-title":"Arterial disease and venous thrombosis: are they related, and if so, what should we do about it?","volume":"4","author":"Lowe","year":"2006","journal-title":"J Thromb Haemost"},{"key":"2026020922055355600_jvim15463-bib-0140","doi-asserted-by":"crossref","first-page":"1748","DOI":"10.1161\/01.CIR.0000035277.48823.01","article-title":"Acute pulmonary embolism: don't ignore the platelet","volume":"106","author":"Sobieszczyk","year":"2002","journal-title":"Circulation"},{"key":"2026020922055355600_jvim15463-bib-0141","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1097\/MBC.0b013e3283602a03","article-title":"Cross-modulatory effects of clopidogrel and heparin on platelet and fibrin incorporation in thrombosis","volume":"24","author":"Cooley","year":"2013","journal-title":"Blood Coagul Fibrinolysis"},{"key":"2026020922055355600_jvim15463-bib-0142","doi-asserted-by":"crossref","first-page":"1295","DOI":"10.1016\/S0140-6736(00)02110-3","article-title":"Prevention of pulmonary embolism and deep vein thrombosis with low dose aspirin: Pulmonary Embolism Prevention (PEP) trial","volume":"355","author":"Group PEPPtC","year":"2000","journal-title":"Lancet"},{"key":"2026020922055355600_jvim15463-bib-0143","doi-asserted-by":"crossref","first-page":"1979","DOI":"10.1056\/NEJMoa1210384","article-title":"Low-dose aspirin for preventing recurrent venous thromboembolism","volume":"367","author":"Brighton","year":"2012","journal-title":"N Engl J Med"},{"key":"2026020922055355600_jvim15463-bib-0144","doi-asserted-by":"crossref","first-page":"933","DOI":"10.1182\/blood-2011-03-344333","article-title":"Aspirin or enoxaparin thromboprophylaxis for patients with newly diagnosed multiple myeloma treated with lenalidomide","volume":"119","author":"Larocca","year":"2012","journal-title":"Blood"},{"key":"2026020922055355600_jvim15463-bib-0145","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1016\/j.jjcc.2014.02.028","article-title":"Frequency of deep vein thrombosis among hospitalized non-surgical Japanese patients with congestive heart failure","volume":"64","author":"Matsuo","year":"2014","journal-title":"J Cardiol"},{"key":"2026020922055355600_jvim15463-bib-0146","doi-asserted-by":"crossref","first-page":"7S","DOI":"10.1378\/chest.1412S3","article-title":"Executive summary: antithrombotic therapy and prevention of thrombosis, 9th ed: American College of Chest Physicians evidence-based clinical practice guidelines","volume":"141","author":"Guyatt","year":"2012","journal-title":"Chest"},{"key":"2026020922055355600_jvim15463-bib-0147","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1016\/j.chest.2015.11.026","article-title":"Antithrombotic therapy for VTE disease: CHEST guideline and expert panel report","volume":"149","author":"Kearon","year":"2016","journal-title":"Chest"},{"key":"2026020922055355600_jvim15463-bib-0148","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1097\/EJA.0000000000000729","article-title":"European guidelines on perioperative venous thromboembolism prophylaxis: executive summary","volume":"35","author":"Afshari","year":"2018","journal-title":"Eur J Anaesthesiol"},{"key":"2026020922055355600_jvim15463-bib-0149","doi-asserted-by":"crossref","first-page":"125","DOI":"10.5326\/0450125","article-title":"A prospective study of unfractionated heparin therapy in dogs with primary immune-mediated hemolytic anemia","volume":"45","author":"Breuhl","year":"2009","journal-title":"J Am Anim Hosp Assoc"},{"key":"2026020922055355600_jvim15463-bib-0150","doi-asserted-by":"crossref","first-page":"1577","DOI":"10.2460\/ajvr.73.10.1577","article-title":"Viscoelastic pharmacodynamics after dalteparin administration to healthy dogs","volume":"73","author":"Brainard","year":"2012","journal-title":"Am J Vet Res"},{"key":"2026020922055355600_jvim15463-bib-0151","first-page":"103","article-title":"Pharmacokinetics of the low molecular weight heparin Fragmin (R) D in dogs","volume":"113","author":"Grebe","year":"2000","journal-title":"Berl Munch Tierarztl Wochenschr"},{"key":"2026020922055355600_jvim15463-bib-0152","doi-asserted-by":"crossref","first-page":"261","DOI":"10.5326\/0450261","article-title":"Pharmacokinetics of subcutaneous low molecular weight heparin (enoxaparin) in dogs","volume":"45","author":"Lunsford","year":"2009","journal-title":"J Am Anim Hosp Assoc"},{"key":"2026020922055355600_jvim15463-bib-0153","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1016\/j.tvjl.2016.01.018","article-title":"Enoxaparin has no significant anticoagulation activity in healthy Beagles at a dose of 0.8 mg\/kg four times daily","volume":"210","author":"Pouzot-Nevoret","year":"2016","journal-title":"Vet J"},{"key":"2026020922055355600_jvim15463-bib-0154","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1016\/0049-3848(85)90137-9","article-title":"Comparative effects of heparin and PK 10169, a low molecular weight fraction, in a canine model of arterial thrombosis","volume":"38","author":"Mestre","year":"1985","journal-title":"Thromb Res"},{"key":"2026020922055355600_jvim15463-bib-0155","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1016\/S0049-3848(00)00334-0","article-title":"Anti-thrombotic efficacies of enoxaparin, dalteparin, and unfractionated heparin in venous thrombo-embolism","volume":"100","author":"Morris","year":"2000","journal-title":"Thromb Res"},{"key":"2026020922055355600_jvim15463-bib-0156","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1111\/vec.12206","article-title":"Clinical experience of anti-Xa monitoring in critically ill dogs receiving dalteparin","volume":"24","author":"Lynch","year":"2014","journal-title":"J Vet Emerg Crit Care"},{"key":"2026020922055355600_jvim15463-bib-0157","doi-asserted-by":"crossref","first-page":"1793","DOI":"10.2460\/ajvr.1980.41.11.1793","article-title":"Activated coagulation time in monitoring heparinized dogs","volume":"41","author":"Green","year":"1980","journal-title":"Am J Vet Res"},{"key":"2026020922055355600_jvim15463-bib-0158","doi-asserted-by":"crossref","first-page":"1460","DOI":"10.2460\/ajvr.1985.46.07.1460","article-title":"Effect of sodium heparin and antithrombin III concentration on activated partial thromboplastin time in the dog","volume":"46","author":"Hellebrekers","year":"1985","journal-title":"Am J Vet Res"},{"key":"2026020922055355600_jvim15463-bib-0159","doi-asserted-by":"crossref","first-page":"588","DOI":"10.1177\/104063870301500615","article-title":"Heparin in vitro sensitivity of the activated partial thromboplastin time in canine plasma depends on reagent","volume":"15","author":"Mischke","year":"2003","journal-title":"J Vet Diagn Invest"},{"key":"2026020922055355600_jvim15463-bib-0160","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1111\/j.1939-1676.2012.00907.x","article-title":"Sonoclot(R) evaluation of single- and multiple-dose subcutaneous unfractionated heparin therapy in healthy adult dogs","volume":"26","author":"Babski","year":"2012","journal-title":"J Vet Intern Med"},{"key":"2026020922055355600_jvim15463-bib-0161","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1111\/j.1939-165X.2008.00068.x","article-title":"In vitro heparinization of canine whole blood with low molecular weight heparin (dalteparin) significantly and dose-dependently prolongs heparinase-modified tissue factor-activated thromboelastography parameters and prothrombinase-induced clotting time","volume":"37","author":"Jessen","year":"2008","journal-title":"Vet Clin Pathol"},{"key":"2026020922055355600_jvim15463-bib-0162","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1111\/vec.12526","article-title":"Thromboelastographic monitoring of the effect of unfractionated heparin in healthy dogs","volume":"27","author":"McLaughlin","year":"2017","journal-title":"J Vet Emerg Crit Care"},{"key":"2026020922055355600_jvim15463-bib-0163","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1111\/j.1939-165X.2011.00282.x","article-title":"Monitoring unfractionated heparin therapy in dogs by measuring thrombin generation","volume":"40","author":"Allegret","year":"2011","journal-title":"Vet Clin Pathol"},{"key":"2026020922055355600_jvim15463-bib-0164","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1111\/vcp.12489","article-title":"Effect of dalteparin administration on thrombin generation kinetics in healthy dogs","volume":"46","author":"Gara-Boivin","year":"2017","journal-title":"Vet Clin Pathol"},{"key":"2026020922055355600_jvim15463-bib-0165","author":"Hanel","year":"2017"},{"issue":"3","key":"2026020922055355600_jvim15463-bib-0166","first-page":"S4","article-title":"Thromboelastography or activated partial thromboplastin time for heparin anticoagulation to prevent thrombosis: the TOP HATT trial","volume":"27","author":"Hanel","year":"2017","journal-title":"J Vet Emerg Crit Care"},{"key":"2026020922055355600_jvim15463-bib-0167","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1161\/01.CIR.12.4.553","article-title":"Studies in intravascular coagulation. IV. The effect of heparin and dicumarol on serum-induced venous thrombosis","volume":"12","author":"Wessler","year":"1955","journal-title":"Circulation"},{"key":"2026020922055355600_jvim15463-bib-0168","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1056\/NEJM197208172870703","article-title":"A prospective study of the value of monitoring heparin treatment with the activated partial thromboplastin time","volume":"287","author":"Basu","year":"1972","journal-title":"N Engl J Med"},{"key":"2026020922055355600_jvim15463-bib-0169","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1182\/blood.V49.2.171.171","article-title":"Relationship between the anticoagulant and antithrombotic effects of heparin in experimental venous thrombosis","volume":"49","author":"Chiu","year":"1977","journal-title":"Blood"},{"key":"2026020922055355600_jvim15463-bib-0170","doi-asserted-by":"crossref","first-page":"e419S","DOI":"10.1378\/chest.11-2301","article-title":"Antithrombotic therapy for VTE disease antithrombotic therapy and prevention of thrombosis, 9th ed: American College of Chest Physicians evidence-based clinical practice guidelines","volume":"141","author":"Kearon","year":"2012","journal-title":"Chest"},{"key":"2026020922055355600_jvim15463-bib-0171","doi-asserted-by":"crossref","first-page":"822","DOI":"10.2460\/ajvr.71.7.822","article-title":"Pharmacodynamic and pharmacokinetic evaluation of clopidogrel and the carboxylic acid metabolite SR 26334 in healthy dogs","volume":"71","author":"Brainard","year":"2010","journal-title":"Am J Vet Res"},{"key":"2026020922055355600_jvim15463-bib-0172","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1016\/j.jvc.2017.03.002","article-title":"Mitral valve repair in dogs using an ePTFE chordal implantation device: a pilot study","volume":"19","author":"Borgarelli","year":"2017","journal-title":"J Vet Cardiol"},{"key":"2026020922055355600_jvim15463-bib-0173","doi-asserted-by":"crossref","first-page":"1296","DOI":"10.1055\/s-0037-1616065","article-title":"Thrombostatin inhibits cyclic flow variations in stenosed canine coronary arteries","volume":"86","author":"Hasa","year":"2001","journal-title":"Thromb Haemost"},{"key":"2026020922055355600_jvim15463-bib-0174","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1016\/j.thromres.2009.06.029","article-title":"Comparison of ticagrelor and thienopyridine P2Y(12) binding characteristics and antithrombotic and bleeding effects in rat and dog models of thrombosis\/hemostasis","volume":"124","author":"van Giezen","year":"2009","journal-title":"Thromb Res"},{"key":"2026020922055355600_jvim15463-bib-0175","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1016\/j.thromres.2013.01.029","article-title":"High-dose aspirin in dogs increases vascular resistance with limited additional anti-platelet effect when combined with potent P2Y12 inhibition","volume":"131","author":"Bjorkman","year":"2013","journal-title":"Thromb Res"},{"key":"2026020922055355600_jvim15463-bib-0176","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1161\/01.STR.4.3.387","article-title":"Effect of aspirin on experimentally induced arterial thrombosis during the healing phase","volume":"4","author":"Dyken","year":"1973","journal-title":"Stroke"},{"key":"2026020922055355600_jvim15463-bib-0177","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1111\/jvim.12022","article-title":"Cyclooxygenase expression and platelet function in healthy dogs receiving low-dose aspirin","volume":"27","author":"Dudley","year":"2013","journal-title":"J Vet Intern Med"},{"key":"2026020922055355600_jvim15463-bib-0178","doi-asserted-by":"crossref","first-page":"1294","DOI":"10.2460\/ajvr.71.11.1294","article-title":"Influence of treatment with ultralow-dose aspirin on platelet aggregation as measured by whole blood impedance aggregometry and platelet P-selectin expression in clinically normal dogs","volume":"71","author":"Sharpe","year":"2010","journal-title":"Am J Vet Res"},{"key":"2026020922055355600_jvim15463-bib-0179","doi-asserted-by":"crossref","first-page":"251","DOI":"10.2460\/ajvr.68.3.251","article-title":"Changes in platelet function, hemostasis, and prostaglandin expression after treatment with nonsteroidal anti-inflammatory drugs with various cyclooxygenase selectivities in dogs","volume":"68","author":"Brainard","year":"2007","journal-title":"Am J Vet Res"},{"key":"2026020922055355600_jvim15463-bib-0180","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1111\/j.1939-165X.2007.tb00222.x","article-title":"Platelet function in dogs: breed differences and effect of acetylsalicylic acid administration","volume":"36","author":"Nielsen","year":"2007","journal-title":"Vet Clin Pathol"},{"key":"2026020922055355600_jvim15463-bib-0181","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1111\/jvp.12432","article-title":"Effects of aspirin dose escalation on platelet function and urinary thromboxane and prostacyclin levels in normal dogs","volume":"41","author":"McLewee","year":"2017","journal-title":"J Vet Pharmacol Ther"},{"key":"2026020922055355600_jvim15463-bib-0182","doi-asserted-by":"crossref","first-page":"1038","DOI":"10.2460\/ajvr.72.8.1038","article-title":"Evaluation of effects of low-dose aspirin administration on urinary thromboxane metabolites in healthy dogs","volume":"72","author":"Hoh","year":"2011","journal-title":"Am J Vet Res"},{"key":"2026020922055355600_jvim15463-bib-0183","doi-asserted-by":"crossref","first-page":"1631","DOI":"10.2460\/ajvr.1992.53.09.1631","article-title":"Effects of low-dose aspirin and specific thromboxane synthetase inhibition on whole blood platelet aggregation and adenosine triphosphate secretion in healthy dogs","volume":"53","author":"Grauer","year":"1992","journal-title":"Am J Vet Res"},{"key":"2026020922055355600_jvim15463-bib-0184","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1111\/j.1939-1676.2009.0312.x","article-title":"Effects of prednisone alone or prednisone with ultralow-dose aspirin on the gastroduodenal mucosa of healthy dogs","volume":"23","author":"Heather Graham","year":"2009","journal-title":"J Vet Intern Med"},{"key":"2026020922055355600_jvim15463-bib-0185","first-page":"1282","article-title":"Platelet function and endoscopic changes after clopidogrel, aspirin, prednisone, or combination therapy in dogs","volume":"31","author":"Whittemore","year":"2017","journal-title":"J Vet Intern Med"},{"key":"2026020922055355600_jvim15463-bib-0186","first-page":"693","article-title":"Comparison of individually monitored unfractionated heparin versus low-dose aspirin on survival of dogs with immune mediated hemolytic anemia","volume":"23","author":"Orcutt","year":"2009","journal-title":"J Vet Intern Med"}],"container-title":["Journal of Veterinary Internal Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fjvim.15463","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/jvim.15463","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/full-xml\/10.1111\/jvim.15463","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/academic.oup.com\/jvim\/article-pdf\/33\/3\/1141\/66659754\/jvim15463.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/jvim\/article-pdf\/33\/3\/1141\/66659754\/jvim15463.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,2,10]],"date-time":"2026-02-10T03:09:56Z","timestamp":1770692996000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/jvim\/article\/33\/3\/1141\/8448135"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,5,1]]},"references-count":186,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2019,5,1]]}},"URL":"https:\/\/doi.org\/10.1111\/jvim.15463","relation":{},"ISSN":["1939-1676"],"issn-type":[{"value":"1939-1676","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2019,5]]},"published":{"date-parts":[[2019,5,1]]},"assertion":[{"value":"2019-01-29","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2019-02-06","order":1,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2019-03-07","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}